The comprehensive risk assessment test will be clinically validated and have appropriate regulatory approval.
Yes but when is it commercially available??
Why did they leave this out or did I miss something..
.
- Forums
- ASX - By Stock
- GTG
- Ann: World First Comprehensive Risk Test-Breast & Ovarian Cancer
Ann: World First Comprehensive Risk Test-Breast & Ovarian Cancer, page-6
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GTG (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.4¢ |
Change
-0.009(14.3%) |
Mkt cap ! $7.139M |
Open | High | Low | Value | Volume |
6.2¢ | 6.2¢ | 5.3¢ | $58.96K | 1.070M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 39908 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 42382 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 39908 | 0.054 |
1 | 321387 | 0.053 |
1 | 25000 | 0.052 |
5 | 174214 | 0.051 |
3 | 70879 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 42382 | 1 |
0.057 | 10000 | 1 |
0.058 | 10000 | 1 |
0.059 | 73500 | 1 |
0.060 | 19204 | 1 |
Last trade - 15.42pm 15/07/2024 (20 minute delay) ? |
Featured News
GTG (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online